Literature DB >> 18221927

Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.

Donna J Helms1, Debra J Mosure, W Evan Secor, Kimberly A Workowski.   

Abstract

BACKGROUND/
OBJECTIVE: Standard treatment for Trichomonas vaginalis is metronidazole or tinidazole. Hypersensitivity to these drugs has been documented but is poorly understood. Desensitization is an option described in limited reports of women with hypersensitivity to nitroimidazoles. The purpose of this analysis is to improve documentation of management for trichomonas infections among women with metronidazole hypersensitivity. STUDY
DESIGN: Clinicians who consulted Centers for Disease Control and Prevention concerning patients with suspected hypersensitivity to metronidazole were provided with treatment options and asked to report outcomes.
RESULTS: From September 2003-September 2006, complete information was obtained for 59 women. The most common reactions were urticaria (47%) and facial edema (11%). Fifteen of these women (25.4%) were treated with metronidazole desensitization and all had eradication of their infection. Seventeen women (28.8%) were treated with alternative intravaginal drugs, which were less successful; 5 of 17 infections (29.4%) were eradicated.
CONCLUSION: Metronidazole desensitization was effective in the management of women with nitroimidazole hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221927     DOI: 10.1016/j.ajog.2007.10.795

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Diagnostic Value of Vaginal Discharge, Wet Mount and Vaginal pH - An Update on the Basics of Gynecologic Infectiology.

Authors:  W Frobenius; C Bogdan
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

3.  Trichomonas vaginalis: treatment questions and challenges.

Authors:  W Evan Secor
Journal:  Expert Rev Anti Infect Ther       Date:  2012-02       Impact factor: 5.091

4.  First report of anti-Trichomonas vaginalis activity of the medicinal plant Polygala decumbens from the Brazilian semi-arid region, Caatinga.

Authors:  Amanda Piccoli Frasson; Odelta dos Santos; Mariana Duarte; Danielle da Silva Trentin; Raquel Brandt Giordani; Alexandre Gomes da Silva; Márcia Vanusa da Silva; Tiana Tasca; Alexandre José Macedo
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

Review 5.  Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Authors:  Kawthar Bouchemal; Christian Bories; Philippe M Loiseau
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 6.  Management of Resistant Trichomoniasis.

Authors:  Cynthia Alessio; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2019-08-06       Impact factor: 3.725

7.  Trichomonas vaginalis genital infections: progress and challenges.

Authors:  Laura H Bachmann; Marcia M Hobbs; Arlene C Seña; Jack D Sobel; Jane R Schwebke; John N Krieger; R Scott McClelland; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

Review 8.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

Review 9.  Trichomoniasis: the "neglected" sexually transmitted disease.

Authors:  Elissa Meites
Journal:  Infect Dis Clin North Am       Date:  2013-10-25       Impact factor: 5.982

10.  Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects.

Authors:  Megan R Miller; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.